0000200406false00002004062025-04-242025-04-240000200406us-gaap:CommonStockMember2025-04-242025-04-240000200406jnj:A1.150NotesDueNovember2028Member2025-04-242025-04-240000200406jnj:A2.700NotesDueFebruary2029Member2025-04-242025-04-240000200406jnj:A3.20NotesDueNovember2032Member2025-04-242025-04-240000200406jnj:A3.050NotesDueFebruary2033Member2025-04-242025-04-240000200406jnj:A1.650NotesDue2035Member2025-04-242025-04-240000200406jnj:A3.350NotesDueNovember2036Member2025-04-242025-04-240000200406jnj:A3.350NotesDueFebruary2037Member2025-04-242025-04-240000200406jnj:A3.550NotesDueNovember2044Member2025-04-242025-04-240000200406jnj:A3.600NotesDueFebruary2045Member2025-04-242025-04-240000200406jnj:A3.700NotesDueFebruary2055Member2025-04-242025-04-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): 
April 24, 2025
Johnson & Johnson
(Exact name of registrant as specified in its charter)
New Jersey1-321522-1024240
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933 
(Address of Principal Executive Offices)
 (Zip Code) 
Registrant's telephone number, including area code:
732-524-0400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Par Value $1.00JNJNew York Stock Exchange
1.150% Notes Due November 2028JNJ28New York Stock Exchange
2.700% Notes due February 2029JNJ29BNew York Stock Exchange
3.200% Notes Due June 2032JNJ32New York Stock Exchange
3.050% Notes due February 2033JNJ33BNew York Stock Exchange
1.650% Notes Due May 2035JNJ35New York Stock Exchange
3.350% Notes Due June 2036JNJ36ANew York Stock Exchange
3.350% Notes due February 2037JNJ37BNew York Stock Exchange
3.550% Notes Due June 2044JNJ44New York Stock Exchange
3.600% Notes due February 2045JNJ45New York Stock Exchange
3.700% Notes due February 2055JNJ55New York Stock Exchange


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
D. Adamczyk notified the Company that he intends to retire from the Company’s Board of Directors in connection with an announcement on April 23rd that he will join Goldman Sachs as a Partner. The retirement will be effective May 31, 2025. His retirement is for personal reasons and not as a result of any disagreement with management on any matter relating to the Company’s operations, policies, or practices.

Item 5.07 Submission of Matters to a Vote of Security Holders.
(a)    The 2025 Annual Meeting of Shareholders of the Company was held on April 24, 2025.
(b)    At the 2025 Annual Meeting of Shareholders, the shareholders:
•elected all 11 Director nominees named in the 2025 Proxy Statement to the Company’s Board of Directors;
•approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the “Compensation Discussion and Analysis” section of the 2025 Proxy Statement and the compensation of the Company’s executive officers named in the 2025 Proxy Statement, as disclosed therein;
•ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2025;
•did not approve the shareholder proposal for shareholder opportunity to vote on excessive golden parachutes; and
•did not approve the shareholder proposal to produce a human rights impact assessment.

The following are the final voting results for each of the five items voted on at the meeting.
1.    Election of Directors:
Shares ForShares AgainstShares AbstainNon-Votes
D. Adamczyk1,614,881,43389,638,5984,656,459323,923,987
M. C. Beckerle1,663,840,47441,888,4803,447,536323,923,987
J. A. Doudna1,666,450,02939,271,1733,455,288323,923,987
J. Duato1,575,244,633130,077,8903,853,967323,923,987
M. A. Hewson1,654,870,63850,832,3313,473,521323,923,987
P. A. Johnson1,667,900,55837,823,3713,452,561323,923,987
H. Joly1,650,666,05354,388,9324,121,505323,923,987
M. B. McClellan1,662,883,65842,458,6973,834,135323,923,987
M. A. Weinberger1,630,170,83374,418,3494,587,308323,923,987
N. Y. West1,660,661,95645,083,9073,430,627323,923,987
E. A. Woods1,635,362,50269,986,0753,827,913323,923,987

2.    Advisory vote to approve named executive officer compensation (Say on Pay):
ForAgainstAbstainedNon-Votes
1,559,332,581142,483,9007,360,009323,923,987




3.    Ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025:
ForAgainstAbstainedNon-Votes
1,888,169,154140,927,8854,003,4380

4.    Shareholder Proposal - shareholder opportunity to vote on excessive golden parachutes:
ForAgainstAbstainedNon-Votes
92,601,5251,609,744,6416,830,324323,923,987

5.    Shareholder Proposal - produce a human rights impact assessment:
ForAgainstAbstainedNon-Votes
188,350,8321,498,659,16922,166,489323,923,987

Item 9.01 Financial statements and exhibits
(d)    Exhibits.
Exhibit No.Description of Exhibit
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.


Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 30, 2025
JOHNSON & JOHNSON
(Registrant)
By:
/s/ Marc Larkins
Marc Larkins
Corporate Secretary

v3.25.1
Cover
Apr. 24, 2025
Cover [Abstract]  
Document Period End Date Apr. 24, 2025
Document Type 8-K
Entity Registrant Name Johnson & Johnson
Entity Incorporation, State or Country Code NJ
Entity File Number 1-3215
Entity Tax Identification Number 22-1024240
Entity Address, Address Line One One Johnson & Johnson Plaza
Entity Address, City or Town New Brunswick
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08933
City Area Code 732
Local Phone Number 524-0400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Document Information [Line Items]  
Entity Emerging Growth Company false
Entity Central Index Key 0000200406
Amendment Flag false
Common Stock  
Cover [Abstract]  
Title of 12(b) Security Common Stock, Par Value $1.00
Document Information [Line Items]  
Title of 12(b) Security Common Stock, Par Value $1.00
Trading Symbol JNJ
Security Exchange Name NYSE
Trading Symbol JNJ
Security Exchange Name NYSE
1.150% Notes Due November 2028  
Cover [Abstract]  
Title of 12(b) Security 1.150% Notes Due November 2028
Document Information [Line Items]  
Title of 12(b) Security 1.150% Notes Due November 2028
Trading Symbol JNJ28
Security Exchange Name NYSE
Trading Symbol JNJ28
Security Exchange Name NYSE
1.650% Notes Due 2035  
Cover [Abstract]  
Title of 12(b) Security 1.650% Notes Due May 2035
Document Information [Line Items]  
Title of 12(b) Security 1.650% Notes Due May 2035
Trading Symbol JNJ35
Security Exchange Name NYSE
Trading Symbol JNJ35
Security Exchange Name NYSE
3.20% Notes Due November 2032  
Cover [Abstract]  
Title of 12(b) Security 3.200% Notes Due June 2032
Document Information [Line Items]  
Title of 12(b) Security 3.200% Notes Due June 2032
Trading Symbol JNJ32
Security Exchange Name NYSE
Trading Symbol JNJ32
Security Exchange Name NYSE
3.350% Notes Due November 2036  
Cover [Abstract]  
Title of 12(b) Security 3.350% Notes Due June 2036
Document Information [Line Items]  
Title of 12(b) Security 3.350% Notes Due June 2036
Trading Symbol JNJ36A
Security Exchange Name NYSE
Trading Symbol JNJ36A
Security Exchange Name NYSE
3.550% Notes Due November 2044  
Cover [Abstract]  
Title of 12(b) Security 3.550% Notes Due June 2044
Document Information [Line Items]  
Title of 12(b) Security 3.550% Notes Due June 2044
Trading Symbol JNJ44
Security Exchange Name NYSE
Trading Symbol JNJ44
Security Exchange Name NYSE
2.700% Notes due February 2029  
Cover [Abstract]  
Title of 12(b) Security 2.700% Notes due February 2029
Document Information [Line Items]  
Title of 12(b) Security 2.700% Notes due February 2029
Trading Symbol JNJ29B
Security Exchange Name NYSE
Trading Symbol JNJ29B
Security Exchange Name NYSE
3.050% Notes due February 2033  
Cover [Abstract]  
Title of 12(b) Security 3.050% Notes due February 2033
Document Information [Line Items]  
Title of 12(b) Security 3.050% Notes due February 2033
Trading Symbol JNJ33B
Security Exchange Name NYSE
Trading Symbol JNJ33B
Security Exchange Name NYSE
3.350% Notes due February 2037  
Cover [Abstract]  
Title of 12(b) Security 3.350% Notes due February 2037
Document Information [Line Items]  
Title of 12(b) Security 3.350% Notes due February 2037
Trading Symbol JNJ37B
Security Exchange Name NYSE
Trading Symbol JNJ37B
Security Exchange Name NYSE
3.600% Notes due February 2045  
Cover [Abstract]  
Title of 12(b) Security 3.600% Notes due February 2045
Document Information [Line Items]  
Title of 12(b) Security 3.600% Notes due February 2045
Trading Symbol JNJ45
Security Exchange Name NYSE
Trading Symbol JNJ45
Security Exchange Name NYSE
3.700% Notes due February 2055  
Cover [Abstract]  
Title of 12(b) Security 3.700% Notes due February 2055
Document Information [Line Items]  
Title of 12(b) Security 3.700% Notes due February 2055
Trading Symbol JNJ55
Security Exchange Name NYSE
Trading Symbol JNJ55
Security Exchange Name NYSE
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Mai 2025 até Jun 2025 Click aqui para mais gráficos Johnson and Johnson.
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Jun 2024 até Jun 2025 Click aqui para mais gráficos Johnson and Johnson.